These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 3371416)
21. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Plöckinger U; Quabbe HJ Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331 [TBL] [Abstract][Full Text] [Related]
22. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. Daughaday WH; Starkey RH; Saltman S; Gavin JR; Mills-Dunlap B; Heath-Monnig E J Clin Endocrinol Metab; 1987 Oct; 65(4):617-23. PubMed ID: 3654910 [TBL] [Abstract][Full Text] [Related]
23. Assay of somatomedin C by cartridge extraction prior to radioimmunoassay with antiserum developed against synthetic somatomedin C. Kao PC; Tateishi K; Abboud CF; Zimmerman D; Randall RV; Li CH Ann Clin Lab Sci; 1988; 18(2):120-30. PubMed ID: 2454603 [TBL] [Abstract][Full Text] [Related]
24. Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. Takamoto S; Tsuchiya H; Onishi T; Morimoto S; Imanaka S; Mori S; Seino Y; Uozumi T; Kumahara Y J Clin Endocrinol Metab; 1985 Jul; 61(1):7-11. PubMed ID: 3839000 [TBL] [Abstract][Full Text] [Related]
25. Diabetes mellitus following pituitary adenomectomy in euglycemic patients with acromegaly. Larijani B; Nakhjavani M; Baradar-Jalili R; Akrami SM; Bandarian F J Coll Physicians Surg Pak; 2005 Jul; 15(7):430-2. PubMed ID: 16197874 [TBL] [Abstract][Full Text] [Related]
26. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C. Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607 [TBL] [Abstract][Full Text] [Related]
27. Acromegaly in an infant. Blumberg DL; Sklar CA; David R; Rothenberg S; Bell J Pediatrics; 1989 Jun; 83(6):998-1002. PubMed ID: 2657629 [TBL] [Abstract][Full Text] [Related]
28. Therapy of acromegaly with sandostatin: the predictive value of an acute test, the value of serum somatomedin-C measurements in dose adjustment and the definition of a biochemical 'cure'. Lamberts SW; Uitterlinden P; Schuijff PC; Klijn JG Clin Endocrinol (Oxf); 1988 Oct; 29(4):411-20. PubMed ID: 3251673 [TBL] [Abstract][Full Text] [Related]
30. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444 [TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly. Barreca A; Ciccarelli E; Minuto F; Bruzzi P; Giordano G; Camanni F Acta Endocrinol (Copenh); 1989 May; 120(5):629-35. PubMed ID: 2728807 [TBL] [Abstract][Full Text] [Related]
32. Lipid metabolism in acromegalic patients before and after selective pituitary adenomectomy. Tsuchiya H; Onishi T; Mogami H; Iida M Endocrinol Jpn; 1990 Dec; 37(6):797-807. PubMed ID: 2129301 [TBL] [Abstract][Full Text] [Related]
33. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. Rieu M; Girard F; Bricaire H; Binoux M J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736 [No Abstract] [Full Text] [Related]
34. Acromegaly: biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy. Serri O; Somma M; Comtois R; Rasio E; Beauregard H; Jilwan N; Hardy J J Clin Endocrinol Metab; 1985 Dec; 61(6):1185-9. PubMed ID: 4055986 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. Clemmons DR; Van Wyk JJ; Ridgway EC; Kliman B; Kjellberg RN; Underwood LE N Engl J Med; 1979 Nov; 301(21):1138-42. PubMed ID: 492275 [TBL] [Abstract][Full Text] [Related]
36. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery. Edén S; Bengtsson BA; Albertsson-Wikland K; Elfversson J; Lindstedt G; Lundberg PA; Petruson B; Rosberg S Acta Endocrinol (Copenh); 1989 Jan; 120(1):113-20. PubMed ID: 2492135 [TBL] [Abstract][Full Text] [Related]
37. Gonadal steroids influence serum somatomedin-C concentrations in prepubertal female rhesus monkey. Wilson ME Endocrinology; 1986 Aug; 119(2):666-71. PubMed ID: 3732141 [TBL] [Abstract][Full Text] [Related]
38. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response. Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567 [TBL] [Abstract][Full Text] [Related]
39. Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly. de la Piedra C; Larrañaga J; Castro N; Horcajada C; Rapado A; Herrera Pombo JL; Carbó E Calcif Tissue Int; 1988 Jul; 43(1):44-5. PubMed ID: 3145120 [TBL] [Abstract][Full Text] [Related]
40. Growth hormone, body composition and somatomedin C after treatment of acromegaly. McLellan AR; Connell JM; Beastall GH; Teasdale G; Davies DL Q J Med; 1988 Dec; 69(260):997-1008. PubMed ID: 3270086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]